Press release
Cisatracurium Besylate Injection Market Trends, Business Overview, Industry Growth and Forecast to 2028
The global cisatracurium besylate injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Cisatracurium besylate injection is a non-depolarizing skeletal neuromuscular blocking agent with an intermediate onset to facilitate non-emergency endotracheal intubation and to provide skeletal muscle relaxation during surgery. The global market is growing due to the increasing number of surgical procedures globally. According to PubMed, around 234.2 million major surgical procedures are performed every year globally. The increasing awareness among individuals about chronic diseases and the availability of advanced treatments is also driving the growth of the market. The supportive government initiatives, as well as huge investment by major manufacturers for research and development, are also driving the growth of the global cisatracurium besylate injection market.The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new drug launches, to stay competitive in the market. For instance-
•In September 2020, Zydus Group received USFDA approval to market Cisatracurium Besylate injection. The drug will be manufactured at the Liva plant (Vadodara) of Zydus Group.
•In September 2020, USFDA approved an abbreviated new drug application for cisatracurium besylate USP 20 mg/10mL named 'Nimbex', which is indicated to facilitate tracheal intubation and provides skeletal muscle relaxation during surgery or mechanical ventilation.
•In May 2020, AuroMedics Pharma LLC received USFDA approval to manufacture and market Cisatracurium Besylate Injection USP, 20 mg/10mL in multiple-dose vials.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Cisatracurium Besylate Injection Market at: https://orionmarketreports.com/request-sample/?id=104581&submit=Request+Sample%0D%0A
Market Coverage
•The market number available for - 2022-2028
•Base year- 2021
•Forecast period- 2022-2028
•Segment Covered-
•By Application
•Regions Covered-
•North America
•Europe
•Asia-Pacific
•Rest of the World
Competitive Landscape- B. Braun Melsungen AG, BD, Baxter, Pfizer Inc., and Fresenius Kabi AG, among others.
A full report Cisatracurium Besylate Injection Market of is available at: https://orionmarketreports.com/cisatracurium-besylate-injection-market/104581/
Global Cisatracurium Besylate Injection Market Report by Segment
By Application
•Hospital
•Clinics
•Recovery Center
Key questions addressed by the report
•What is the market growth rate?
•Which segment and region dominate the market in the base year?
•Which segment and region will project the fastest growth in the market?
•How has COVID-19 impacted the market?
•Deviation from the pre-COVID-19 forecast
•Most affected region and segment
•Who is the leader in the market?
•How players are addressing challenges to sustain growth?
•Where is the investment opportunity?
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cisatracurium Besylate Injection Market Trends, Business Overview, Industry Growth and Forecast to 2028 here
News-ID: 2616974 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Cisatracurium
Cisatracurium Besylate Market Current Status and Future Prospects till 2033
Cisatracurium Besylate Market Revenue was valued at USD 300 Million in 2024 and is estimated to reach USD 500 Million by 2033, growing at a CAGR of 6.0% from 2026 to 2033.
Cisatracurium Besylate Market Outlook & Investment Analysis
1. What is the current outlook of the Cisatracurium Besylate market?
The Cisatracurium Besylate market has shown significant growth driven by its widespread use as a muscle relaxant during surgeries and critical care. It…
Cisatracurium Besylate Market | Exploring Current Trends and Growth Status for 2 …
Cisatracurium Besylate Market Revenue was valued at USD 300 Million in 2024 and is estimated to reach USD 500 Million by 2033, growing at a CAGR of 6.0% from 2026 to 2033.
Cisatracurium Besylate Market Outlook & Investment Analysis
What is the current outlook of the Cisatracurium Besylate market?
The Cisatracurium Besylate market has shown significant growth driven by its widespread use as a muscle relaxant during surgeries and critical care. It is…
Best Statistical Cisatracurium Besylate Market Growth Set to Surge Significantly …
Introducing our exclusive "Cisatracurium Besylate Market Insights Report 2023", Uncover a world of market insights and data-driven intelligence that will propel your business to new heights. This comprehensive and meticulously curated report is a treasure trove of invaluable insights and data, providing a profound understanding of market trends, growth opportunities, competitive analysis, and more, empowering you to make informed decisions with confidence. Whether you're a startup looking for a foothold…
Global Cisatracurium Besylate Depth Research Report 2021| Aspen Pharmacare, AbbV …
Complete study of the global Cisatracurium Besylate market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Cisatracurium Besylate industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also…
Cisatracurium Besylate Injection Market Study for 2020 to 2026 Providing Informa …
Cisatracurium Besylate Injection Complete study of the global Cisatracurium Besylate Injection market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Cisatracurium Besylate Injection industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by…
Cisatracurium Besylate Market Analysis 2020-2026 with Industry Leaders Profiles, …
Complete study of the global Cisatracurium Besylate market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Cisatracurium Besylate industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also…